Acceptable Blood Pressure on Vyvanse for Adults 50-64
Vyvanse raises systolic BP 2 to 6 mmHg and heart rate 4 to 6 bpm on average. See safe ranges, dosing, and monitoring steps for ages 50 to 64.
Vyvanse
45 source-based articles maintained by the HealthRX.com Editorial Team.
45articles
6topic areas covered
May 26, 2026latest review
Vyvanse library
Showing 45 of 45 clinical reviews.
Does Aetna (CVS Health) Cover Vyvanse? Prior Authorization, Formulary Tier, and Appeal Steps
Aetna (CVS Health) covers Vyvanse for ADHD and binge eating disorder with prior authorization and step therapy. Learn formulary tier, PA criteria, appeal steps, and how to lower your cost.
Does Blue Cross Blue Shield (Federated) Cover Vyvanse?
Coverage details for Vyvanse (lisdexamfetamine) under Blue Cross Blue Shield Federated plans, including formulary tier, prior authorization requirements, step therapy, and how to appeal a denial.
Does Kaiser Permanente Cover Vyvanse? Formulary, Prior Auth, and Appeal Steps
Kaiser Permanente coverage for Vyvanse (lisdexamfetamine) explained: formulary tier, prior authorization requirements, step therapy, appeal process, and cost-saving alternatives for ADHD and binge eating disorder.
Does State Medicaid Cover Vyvanse? Prior Authorization, Formulary Tiers, and Appeal Steps
State Medicaid coverage for Vyvanse (lisdexamfetamine) varies widely. Learn formulary tiers, prior authorization criteria, step therapy requirements, and how to appeal a denial.
Does TRICARE Cover Vyvanse? Formulary Tier, Prior Authorization, and Appeal Steps
TRICARE covers Vyvanse (lisdexamfetamine) for ADHD and binge eating disorder with prior authorization. Learn formulary placement, step therapy rules, copay costs, and how to appeal a denial.
Does UnitedHealthcare Cover Vyvanse? Formulary Tier, Prior Authorization, and Appeal Steps
UnitedHealthcare commercial plans generally cover Vyvanse (lisdexamfetamine) with prior authorization, often at a non-preferred brand tier. Here is how formulary placement, step therapy, and appeals typically work, and what still needs to be confirmed against your specific plan.
Missed a Vyvanse Dose? Timing, Whole Doses and Next Steps
Forgot Vyvanse? Learn when to skip a dose, why doses must stay whole, what to do after an extra dose, and what to ask your pharmacist.
Stopping Vyvanse: Separate Withdrawal From ADHD and Binge-Eating Relapse
What Vyvanse stopping studies measured, how withdrawal differs from ADHD or binge-eating relapse, and what to record before a prescription change.
Switching From or To Vyvanse: Protocols, Dose Conversions, and Clinical Evidence
What is established, plausible, and unverified about switching between Vyvanse (lisdexamfetamine) and other ADHD stimulants or non-stimulants, including dose conversion logic and a monitoring framework.
Vyvanse (Lisdexamfetamine) After Bariatric Surgery: What Clinicians and Patients Need to Know
A clinical deep-dive into lisdexamfetamine (Vyvanse) pharmacokinetics, dosing, absorption changes, and safety considerations following Roux-en-Y gastric bypass, sleeve gastrectomy, and other bariatric procedures.
Vyvanse (Lisdexamfetamine) and the Kidneys: Renal Protection or Renal Risk?
A clinician-level review of how Vyvanse (lisdexamfetamine) affects kidney function, covering renal excretion pharmacokinetics, blood-pressure-driven risk, dose adjustment in CKD, and what current evidence says about long-term renal safety.
Vyvanse (Lisdexamfetamine) Complete Drug-Drug Interaction Profile
A guide to every clinically significant drug-drug interaction with Vyvanse (lisdexamfetamine), including MAOIs, serotonergic agents, CYP2D6 substrates, antihypertensives, and GI pH modifiers.
Vyvanse (Lisdexamfetamine) Pregnancy & Lactation Safety
An evidence-based guide to lisdexamfetamine (Vyvanse) use during pregnancy and breastfeeding, covering pharmacokinetics, fetal risk data, neonatal outcomes, and clinical decision frameworks.
Vyvanse Adult Dosing (Ages 30 to 49): Starting Dose, Titration, and Optimization
Evidence-based guide to lisdexamfetamine (Vyvanse) dosing for adults aged 30 to 49, covering starting doses, titration schedules, maximum doses for ADHD and binge eating disorder, and midlife clinical considerations.
Vyvanse and Autoimmune Disease: What Clinicians and Patients Need to Know
A clinician-level review of lisdexamfetamine (Vyvanse) use in patients with autoimmune conditions, covering pharmacology, drug interactions, immune-axis effects, and practical prescribing considerations backed by primary literature.
Vyvanse Appetite & Cravings Changes: What the Clinical Evidence Shows
Vyvanse (lisdexamfetamine) is FDA-approved for moderate-to-severe binge eating disorder in adults at 50-70 mg, with roughly 1.6 fewer binge days a week.
Vyvanse Black Box Warning: What It Means for Adults 30-49
Vyvanse carries a boxed warning for stimulant abuse and dependence risk. See real blood pressure, heart rate, and psychiatric data plus monitoring steps for adults.
Vyvanse Bone Health and Density Impact: What the Evidence Shows
A look at how lisdexamfetamine (Vyvanse) affects bone mineral density, fracture risk, and growth in children and adults, with primary literature citations and clinical guidance.
Vyvanse Cardiovascular Impact Long-Term: What the Evidence Actually Shows
An evidence-based review of lisdexamfetamine (Vyvanse) and its long-term cardiovascular effects, including heart rate, blood pressure, arrhythmia risk, and clinical monitoring protocols.
Vyvanse Cognitive Function Impact: What the Clinical Evidence Actually Shows
A deep dive into how lisdexamfetamine (Vyvanse) affects cognitive function in ADHD and binge eating disorder, covering mechanisms, clinical trial data, dosing, and safety.
Vyvanse Cost vs. Alternatives in Class: A Price and Efficacy Comparison
Compare Vyvanse (lisdexamfetamine) costs against generic amphetamine salts, methylphenidate, and other ADHD stimulants. Includes per-pill pricing, insurance data, and head-to-head efficacy evidence.
Vyvanse Dosage for Young Adults - Starting Dose to 70mg
Vyvanse starts at 30mg daily for ages 18-29, regardless of weight or height, titrated 10-20mg weekly to a 70mg max. See dosing steps and duration.
Vyvanse Dosing for Ages 50 to 64: Starting Dose & Max
Vyvanse for adults 50-64 starts at 30 mg each morning, titrated weekly in 10-20 mg steps to a 70 mg max, with added blood pressure checks.
Vyvanse Food and Supplements: Match the Ingredient to the Evidence
Separate capsule mixing, urinary-pH interactions, omeprazole and caffeine study outcomes before interpreting a Vyvanse food or supplement effect.
Vyvanse Hair and Skin Changes: What the Evidence Actually Says
Vyvanse hair and skin evidence: documented sweating, alopecia and skin-picking reports, actual study limits, nutrition, pallor and other skin conditions.
Vyvanse Liver Function Impact: What Patients and Clinicians Need to Know
No, Vyvanse isn't a known liver toxin at therapeutic doses. Lisdexamfetamine is activated in red blood cells, not the liver, so hepatic stress is low.
Vyvanse Mechanism of Action: The Full Pharmacological Pathway From Prodrug to Dopamine Release
A physician-level breakdown of how lisdexamfetamine (Vyvanse) is enzymatically converted to d-amphetamine, its catecholamine release cascade, and why the prodrug design shapes its clinical profile.
Vyvanse Mental Health and Mood Impact: What the Clinical Evidence Actually Shows
Can Vyvanse cause depression? Depressed mood usually shows up as rebound or withdrawal: fatigue, hypersomnia and low mood for 2 to 10 days after stopping.
Vyvanse Monitoring for Adults (30 to 49): Lab Work, Vital Signs, and Follow-Up Schedules
Vyvanse raises systolic blood pressure a mean 1 to 4 mmHg and heart rate 2 to 6 bpm per the FDA label. Check both at each visit, then every 3 to 6 months.
Vyvanse Monitoring Schedule: Labs & Exams Your Prescriber Should Order
A clinician-level guide to the complete Vyvanse (lisdexamfetamine) monitoring schedule, covering baseline labs, follow-up cardiovascular exams, growth tracking, abuse-potential assessments, and when to escalate care.
Vyvanse Off-Label Uses with Evidence Levels
A clinical review of lisdexamfetamine (Vyvanse) off-label uses including treatment-resistant depression, narcolepsy, cognitive fatigue, and obesity, with evidence grading from RCTs to case series.
Vyvanse Patent & Generic Timeline: When Did Exclusivity End and What Changed?
A clinical breakdown of lisdexamfetamine (Vyvanse) patent history, generic availability timeline, and what the shift to generic access means for ADHD and BED patients.
Vyvanse Pharmacogenomics and Genetic Variability
How CYP2D6 polymorphisms, dopamine transporter gene variants, and COMT genotype shape lisdexamfetamine metabolism, efficacy, and side-effect risk.
Vyvanse Pharmacokinetics (ADME): How Lisdexamfetamine Is Absorbed, Distributed, Metabolized, and Excreted
A MD-level breakdown of Vyvanse (lisdexamfetamine) pharmacokinetics covering absorption, distribution, metabolism, and excretion with PubMed-cited evidence and clinical dosing implications.
Vyvanse Plateau and Non-Response Troubleshooting
A clinician-level guide to diagnosing and resolving Vyvanse (lisdexamfetamine) plateau and non-response, covering pharmacokinetics, dose optimization, adherence gaps, comorbidities, and when to switch agents.
Vyvanse Regulatory Status: US, EU, Canada, and UK Explained
Is Vyvanse a controlled substance? Yes: it is DEA Schedule II in the US, CDSA Schedule I in Canada, and a Class B Schedule 2 controlled drug in the UK.
Vyvanse Safety Signals & FDA Actions: What Patients and Prescribers Need to Know
A clinician-grade review of lisdexamfetamine (Vyvanse) safety signals, FDA regulatory actions, boxed warnings, post-market surveillance findings, and risk mitigation strategies for ADHD and binge eating disorder.
Vyvanse Seasonal Use Considerations: A Clinical Guide to Lisdexamfetamine Year-Round
How temperature, light cycles, schedule changes, and seasonal mood shifts affect Vyvanse (lisdexamfetamine) dosing, storage, and clinical management. Board-reviewed guidance with primary-literature citations.
Vyvanse Sleep Architecture Impact: What the Clinical Evidence Shows
The FDA label lists insomnia in 13% of adult ADHD patients on Vyvanse. Taking the dose at 6-8 AM is often the most effective adjustment for sleep problems.
Vyvanse Storage: What Can Be Kept After Opening or Mixing
Learn how to store Vyvanse capsules and chewable tablets, handle opened capsules, and assess expiration dates, travel conditions, and heat exposure.
Vyvanse Travel & Timezone-Shift Protocols: A Clinical Guide for Patients and Prescribers
Evidence-based protocols for traveling across time zones with Vyvanse (lisdexamfetamine). Covers dose-timing adjustments, international scheduling laws, storage requirements, and physician documentation.
Vyvanse Week by Week: What to Expect in Your First Month on Lisdexamfetamine
A week-by-week guide to the first 30 days on Vyvanse (lisdexamfetamine) for ADHD and binge eating disorder, including dose titration, side-effect timelines, and what the clinical evidence actually shows.
Vyvanse Young Adult (18-29) Monitoring: What to Track and How Often
Evidence-based monitoring guide for young adults aged 18-29 taking Vyvanse (lisdexamfetamine) for ADHD or binge eating disorder, covering cardiovascular checks, growth parameters, mental health screening, and lab work.
Vyvanse Young Adult (18-29) Safety: What the Evidence Shows
A clinical guide to lisdexamfetamine (Vyvanse) safety in young adults aged 18-29, covering cardiovascular risks, psychiatric monitoring, reproductive considerations, and long-term use data.